Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. | Front Genet | 2022 | 35664337 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma. | Front Genet | 2022 | 35664309 | PubTator, text mining | PubMed |
| Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. | Front Immunol | 2022 | 35663977 | PubTator, text mining | PubMed |
| Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors. | J Exp Med | 2022 | 35657354 | PubTator, text mining | PubMed |
| The Biological Interaction of SARS-CoV-2 Infection and Osteoporosis: A Preliminary Study. | Front Cell Dev Biol | 2022 | 35646907 | PubTator, text mining | PubMed |
| The perception and response of T cells to a changing environment are based on the law of initial value. | Sci Signal | 2022 | 35639856 | PubTator, text mining | PubMed |
| Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero? | Front Immunol | 2022 | 35634281 | PubTator, text mining | PubMed |
| Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma. | Oxid Med Cell Longev | 2022 | 35633885 | PubTator, text mining | PubMed |
| Identification of Naturally Processed Epitope Region Using Artificial APC Expressing a Single HLA Class I Allotype and mRNA of HCMV pp65 Antigen Fragments. | Vaccines (Basel) | 2022 | 35632543 | PubTator, text mining | PubMed |
| Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get". | Vaccines (Basel) | 2022 | 35632488 | PubTator, text mining | PubMed |
| Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. | Cancers (Basel) | 2022 | 35626062 | PubTator, text mining | PubMed |
| Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2022 | 35626032 | PubTator, text mining | PubMed |
| TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma. | Brain Sci | 2022 | 35625048 | PubTator, text mining | PubMed |
| The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors. | Mol Genet Genomic Med | 2022 | 35621010 | PubTator, text mining | PubMed |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. | iScience | 2022 | 35620424 | PubTator, text mining | PubMed |
| Effect of Extracellular Vesicles From Multiple Cells on Vascular Smooth Muscle Cells in Atherosclerosis. | Front Pharmacol | 2022 | 35620296 | PubTator, text mining | PubMed |
| Emerging roles of cystathionine β-synthase in various forms of cancer. | Redox Biol | 2022 | 35618601 | PubTator, text mining | PubMed |
| Resistance against anti-CD19 and anti-BCMA CAR T cells: Recent advances and coping strategies. | Transl Oncol | 2022 | 35617812 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases. | J Virol | 2022 | 35612313 | PubTator, text mining | PubMed |
| Natural killer cells: a promising immunotherapy for cancer. | J Transl Med | 2022 | 35606854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=47